ATE15760T1 - Lithium enthaltende tabletten mit verzoegerter wirkstoffabgabe, sowie verfahren zu deren herstellung. - Google Patents

Lithium enthaltende tabletten mit verzoegerter wirkstoffabgabe, sowie verfahren zu deren herstellung.

Info

Publication number
ATE15760T1
ATE15760T1 AT83302216T AT83302216T ATE15760T1 AT E15760 T1 ATE15760 T1 AT E15760T1 AT 83302216 T AT83302216 T AT 83302216T AT 83302216 T AT83302216 T AT 83302216T AT E15760 T1 ATE15760 T1 AT E15760T1
Authority
AT
Austria
Prior art keywords
tablets
granulate
lithium carbonate
sustained release
lithium
Prior art date
Application number
AT83302216T
Other languages
English (en)
Inventor
David John Trigger
Original Assignee
Delandale Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delandale Lab Ltd filed Critical Delandale Lab Ltd
Application granted granted Critical
Publication of ATE15760T1 publication Critical patent/ATE15760T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT83302216T 1982-04-30 1983-04-19 Lithium enthaltende tabletten mit verzoegerter wirkstoffabgabe, sowie verfahren zu deren herstellung. ATE15760T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8212636 1982-04-30
EP83302216A EP0093538B1 (de) 1982-04-30 1983-04-19 Lithium enthaltende Tabletten mit verzögerter Wirkstoffabgabe, sowie Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE15760T1 true ATE15760T1 (de) 1985-10-15

Family

ID=10530100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83302216T ATE15760T1 (de) 1982-04-30 1983-04-19 Lithium enthaltende tabletten mit verzoegerter wirkstoffabgabe, sowie verfahren zu deren herstellung.

Country Status (14)

Country Link
EP (1) EP0093538B1 (de)
AT (1) ATE15760T1 (de)
AU (1) AU551212B2 (de)
CA (1) CA1200502A (de)
CY (1) CY1356A (de)
DE (1) DE3360873D1 (de)
EG (1) EG17257A (de)
GB (1) GB2119247B (de)
GR (1) GR78843B (de)
IL (1) IL68482A (de)
MT (1) MTP930B (de)
NZ (1) NZ203959A (de)
PT (1) PT76567B (de)
ZA (1) ZA832799B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
GB9018839D0 (en) * 1990-08-29 1990-10-10 Newton John M Slow release compositions
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
GB9806462D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved compositions for inhalation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209093A (en) * 1968-07-16 1970-10-14 Delandale Lab Ltd Pharmaceutical preparation
GB1450536A (en) * 1972-11-27 1976-09-22 Delandale Lab Ltd Method of making tablets
GB2016922B (en) * 1978-02-17 1982-08-18 Delandale Lab Ltd Sustained release lithium carbonate tables

Also Published As

Publication number Publication date
MTP930B (en) 1984-04-10
IL68482A0 (en) 1983-07-31
IL68482A (en) 1986-12-31
ZA832799B (en) 1984-01-25
EP0093538A1 (de) 1983-11-09
CY1356A (en) 1987-08-07
GB8310535D0 (en) 1983-05-25
GR78843B (de) 1984-10-02
GB2119247B (en) 1985-08-07
NZ203959A (en) 1985-10-11
DE3360873D1 (en) 1985-10-31
GB2119247A (en) 1983-11-16
PT76567A (en) 1983-05-01
CA1200502A (en) 1986-02-11
AU1387983A (en) 1983-11-03
AU551212B2 (en) 1986-04-17
EP0093538B1 (de) 1985-09-25
EG17257A (en) 1991-03-30
PT76567B (en) 1985-12-10

Similar Documents

Publication Publication Date Title
ATE66141T1 (de) Pharmazeutische zusammensetzung.
PT99245A (pt) Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem
CA2270975A1 (en) Stabilized sustained release tramadol formulations
JPS5642550A (en) Preparation of moderately moistened feed having high storability
BR9912846B1 (pt) processo para fabricar um tablete de liberação controlada.
ATE15760T1 (de) Lithium enthaltende tabletten mit verzoegerter wirkstoffabgabe, sowie verfahren zu deren herstellung.
DE2113837B2 (de) Verfahren zur Herstellung einer im wesentlichen kristallwasserfreien Kalium-Magnesiumsulfat-Substanz
GR3015174T3 (en) Soil additive pellets, to feed plants with nitrogen, and process for their production.
JPS56100624A (en) Production of granules
IE38550L (en) Method of making tablets
SU962325A1 (ru) Устройство дл увлажнени и окомковани сыпучих материалов
DE1592573C3 (de) Verfahren zur Herstellung von Moostorf
JPS5226752A (en) Particle medicine ejector
JPS5633043A (en) Improving method for activity of catalyst
GB2023109A (en) Phosphate fertilizers and process for preparing them
RU95111389A (ru) Способ производства гранулированных комбикормов
JPS52134590A (en) Automatic continuous packaging method of pickles, etc.
JPS56115387A (en) Liquefaction of coal
JPS5430204A (en) Charging of coke and other materials into dry cooling equipment
JPS53113848A (en) Preparation of composite material
JPS5230160A (en) Impurity scattering method to semiconductor base plate
JPS57201579A (en) Treatment of fine powdery grain containing iron
JPS52129091A (en) Method of making grinding tool
JPS55134688A (en) Removing ammonia from water
ATE97341T1 (de) Verfahren und vorrichtung zur herstellung von granulaten mittels wirbelbett-technik.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time